Dow has used AAPS 2009 to launch low aldehyde grades of its Carbowax Sentry PEG, which are niche products aimed at formulators seeking to improve shelf life.
Dow Chemical is hoping to push production of its Carbowax Sentry brand of polyethylene glycol ingredients up by a third over 2006/2007 levels by the end of the year, and put the production problems of recent months behind it.
Major chemical manufacturer Dow has struck a deal with long-term
partner Colorcon forming an alliance to offer a unified package for
the development and production of drug ingredients and products.
German drug development company BioGenerix has earmarked up to
$61.5 million (€48m) to develop a new version of an
already-marketed biologic drug using a pegylation technology
developed by US firm Neose, reports Phil Taylor.